| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | aromatase activity | 4.40e-10 | 35 | 102 | 7 | GO:0070330 | |
| GeneOntologyMolecularFunction | alpha-tocopherol omega-hydroxylase activity | 3.20e-09 | 5 | 102 | 4 | GO:0052871 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen | 5.31e-09 | 49 | 102 | 7 | GO:0016712 | |
| GeneOntologyMolecularFunction | leukotriene-B4 20-monooxygenase activity | 2.22e-08 | 7 | 102 | 4 | GO:0050051 | |
| GeneOntologyMolecularFunction | alkane 1-monooxygenase activity | 2.22e-08 | 7 | 102 | 4 | GO:0018685 | |
| GeneOntologyMolecularFunction | arachidonate epoxygenase activity | 1.24e-07 | 24 | 102 | 5 | GO:0008392 | |
| GeneOntologyMolecularFunction | arachidonate omega-hydroxylase activity | 1.32e-07 | 10 | 102 | 4 | GO:0052869 | |
| GeneOntologyMolecularFunction | fatty acid omega-hydroxylase activity | 1.32e-07 | 10 | 102 | 4 | GO:0120250 | |
| GeneOntologyMolecularFunction | long-chain fatty acid omega-hydroxylase activity | 1.32e-07 | 10 | 102 | 4 | GO:0102033 | |
| GeneOntologyMolecularFunction | arachidonate monooxygenase activity | 2.33e-07 | 27 | 102 | 5 | GO:0008391 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen | 4.43e-07 | 13 | 102 | 4 | GO:0016713 | |
| GeneOntologyMolecularFunction | monooxygenase activity | 2.06e-06 | 115 | 102 | 7 | GO:0004497 | |
| GeneOntologyMolecularFunction | heme binding | 1.42e-05 | 154 | 102 | 7 | GO:0020037 | |
| GeneOntologyMolecularFunction | monocarboxylic acid binding | 1.82e-05 | 107 | 102 | 6 | GO:0033293 | |
| GeneOntologyMolecularFunction | tetrapyrrole binding | 2.13e-05 | 164 | 102 | 7 | GO:0046906 | |
| GeneOntologyMolecularFunction | iron ion binding | 2.30e-05 | 166 | 102 | 7 | GO:0005506 | |
| GeneOntologyMolecularFunction | 20-hydroxy-leukotriene B4 omega oxidase activity | 2.58e-05 | 2 | 102 | 2 | GO:0097258 | |
| GeneOntologyMolecularFunction | 20-aldehyde-leukotriene B4 20-monooxygenase activity | 2.58e-05 | 2 | 102 | 2 | GO:0097259 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen | 5.09e-05 | 40 | 102 | 4 | GO:0016709 | |
| GeneOntologyMolecularFunction | arachidonate binding | 5.63e-05 | 15 | 102 | 3 | GO:0050544 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen | 6.22e-05 | 194 | 102 | 7 | GO:0016705 | |
| GeneOntologyMolecularFunction | icosanoid binding | 6.90e-05 | 16 | 102 | 3 | GO:0050542 | |
| GeneOntologyMolecularFunction | icosatetraenoic acid binding | 6.90e-05 | 16 | 102 | 3 | GO:0050543 | |
| GeneOntologyMolecularFunction | carboxylic acid binding | 2.27e-04 | 239 | 102 | 7 | GO:0031406 | |
| GeneOntologyMolecularFunction | nuclear steroid receptor activity | 2.74e-04 | 25 | 102 | 3 | GO:0003707 | |
| GeneOntologyMolecularFunction | organic acid binding | 3.28e-04 | 254 | 102 | 7 | GO:0043177 | |
| GeneOntologyMolecularFunction | long-chain fatty acid binding | 3.86e-04 | 28 | 102 | 3 | GO:0036041 | |
| GeneOntologyMolecularFunction | fatty acid binding | 4.30e-04 | 69 | 102 | 4 | GO:0005504 | |
| GeneOntologyMolecularFunction | pre-mRNA 3'-splice site binding | 5.34e-04 | 7 | 102 | 2 | GO:0030628 | |
| GeneOntologyMolecularFunction | oxygen binding | 8.86e-04 | 37 | 102 | 3 | GO:0019825 | |
| GeneOntologyMolecularFunction | calmodulin binding | 1.17e-03 | 230 | 102 | 6 | GO:0005516 | |
| GeneOntologyMolecularFunction | 1-phosphatidylinositol-3-kinase activity | 1.38e-03 | 11 | 102 | 2 | GO:0016303 | |
| GeneOntologyMolecularFunction | hormone binding | 1.93e-03 | 103 | 102 | 4 | GO:0042562 | |
| GeneOntologyMolecularFunction | retinoic acid 4-hydroxylase activity | 2.26e-03 | 14 | 102 | 2 | GO:0008401 | |
| GeneOntologyMolecularFunction | transcription coactivator binding | 2.66e-03 | 54 | 102 | 3 | GO:0001223 | |
| GeneOntologyMolecularFunction | nuclear receptor activity | 3.59e-03 | 60 | 102 | 3 | GO:0004879 | |
| GeneOntologyMolecularFunction | ligand-activated transcription factor activity | 3.76e-03 | 61 | 102 | 3 | GO:0098531 | |
| GeneOntologyBiologicalProcess | leukotriene B4 catabolic process | 8.06e-09 | 6 | 101 | 4 | GO:0036101 | |
| GeneOntologyBiologicalProcess | leukotriene B4 metabolic process | 1.87e-08 | 7 | 101 | 4 | GO:0036102 | |
| GeneOntologyBiologicalProcess | leukotriene catabolic process | 3.73e-08 | 8 | 101 | 4 | GO:0036100 | |
| GeneOntologyBiologicalProcess | menaquinone catabolic process | 1.14e-07 | 3 | 101 | 3 | GO:0042361 | |
| GeneOntologyBiologicalProcess | icosanoid catabolic process | 1.74e-07 | 11 | 101 | 4 | GO:1901523 | |
| GeneOntologyBiologicalProcess | long-chain fatty acid catabolic process | 2.60e-07 | 12 | 101 | 4 | GO:0042758 | |
| GeneOntologyBiologicalProcess | menaquinone metabolic process | 4.54e-07 | 4 | 101 | 3 | GO:0009233 | |
| GeneOntologyBiologicalProcess | phylloquinone metabolic process | 4.54e-07 | 4 | 101 | 3 | GO:0042374 | |
| GeneOntologyBiologicalProcess | phylloquinone catabolic process | 4.54e-07 | 4 | 101 | 3 | GO:0042376 | |
| GeneOntologyBiologicalProcess | vitamin K catabolic process | 4.54e-07 | 4 | 101 | 3 | GO:0042377 | |
| GeneOntologyBiologicalProcess | prostaglandin catabolic process | 2.26e-06 | 6 | 101 | 3 | GO:1905344 | |
| GeneOntologyBiologicalProcess | prostanoid catabolic process | 2.26e-06 | 6 | 101 | 3 | GO:0062232 | |
| GeneOntologyBiologicalProcess | unsaturated fatty acid metabolic process | 3.19e-06 | 128 | 101 | 7 | GO:0033559 | |
| GeneOntologyBiologicalProcess | fatty acid derivative catabolic process | 3.70e-06 | 22 | 101 | 4 | GO:1901569 | |
| GeneOntologyBiologicalProcess | regulation of small GTPase mediated signal transduction | DOCK3 LPAR4 KBTBD6 RALGAPA2 ARHGEF25 ECT2 KBTBD7 CSNK1A1L ICMT CSNK1A1 | 5.51e-06 | 333 | 101 | 10 | GO:0051056 |
| GeneOntologyBiologicalProcess | monocarboxylic acid metabolic process | CYP3A7 CYP2C18 ACACB CYP4B1 ABHD2 CYP4F2 GSTM2 PLAA SLC22A13 UGT2A3 PKM CYP4F3 CYP4F12 CYP4F11 | 1.29e-05 | 731 | 101 | 14 | GO:0032787 |
| GeneOntologyBiologicalProcess | fatty acid metabolic process | CYP2C18 ACACB CYP4B1 ABHD2 CYP4F2 GSTM2 PLAA SLC22A13 CYP4F3 CYP4F12 CYP4F11 | 1.61e-05 | 461 | 101 | 11 | GO:0006631 |
| GeneOntologyBiologicalProcess | vitamin K metabolic process | 1.83e-05 | 11 | 101 | 3 | GO:0042373 | |
| GeneOntologyBiologicalProcess | arachidonate metabolic process | 2.08e-05 | 68 | 101 | 5 | GO:0019369 | |
| GeneOntologyBiologicalProcess | fatty acid catabolic process | 2.28e-05 | 116 | 101 | 6 | GO:0009062 | |
| GeneOntologyBiologicalProcess | fat-soluble vitamin catabolic process | 2.43e-05 | 12 | 101 | 3 | GO:0042363 | |
| GeneOntologyBiologicalProcess | olefinic compound metabolic process | 2.96e-05 | 180 | 101 | 7 | GO:0120254 | |
| GeneOntologyBiologicalProcess | long-chain fatty acid metabolic process | 3.32e-05 | 124 | 101 | 6 | GO:0001676 | |
| GeneOntologyBiologicalProcess | omega-hydroxylase P450 pathway | 3.99e-05 | 14 | 101 | 3 | GO:0097267 | |
| GeneOntologyBiologicalProcess | carboxylic acid metabolic process | CYP3A7 CYP2C18 ACACB CYP4B1 ABHD2 CYP4F2 IDH3A GSTM2 PLAA ICMT SLC22A13 UGT2A3 PKM CYP4F3 CYP4F12 CYP4F11 | 4.14e-05 | 1035 | 101 | 16 | GO:0019752 |
| GeneOntologyBiologicalProcess | leukotriene metabolic process | 4.77e-05 | 41 | 101 | 4 | GO:0006691 | |
| GeneOntologyBiologicalProcess | oxoacid metabolic process | CYP3A7 CYP2C18 ACACB CYP4B1 ABHD2 CYP4F2 IDH3A GSTM2 PLAA ICMT SLC22A13 UGT2A3 PKM CYP4F3 CYP4F12 CYP4F11 | 5.38e-05 | 1058 | 101 | 16 | GO:0043436 |
| GeneOntologyBiologicalProcess | organic acid metabolic process | CYP3A7 CYP2C18 ACACB CYP4B1 ABHD2 CYP4F2 IDH3A GSTM2 PLAA ICMT SLC22A13 UGT2A3 PKM CYP4F3 CYP4F12 CYP4F11 | 5.75e-05 | 1064 | 101 | 16 | GO:0006082 |
| GeneOntologyBiologicalProcess | icosanoid metabolic process | 7.10e-05 | 142 | 101 | 6 | GO:0006690 | |
| GeneOntologyBiologicalProcess | monocarboxylic acid catabolic process | 7.97e-05 | 145 | 101 | 6 | GO:0072329 | |
| GeneOntologyBiologicalProcess | vitamin catabolic process | 8.82e-05 | 18 | 101 | 3 | GO:0009111 | |
| GeneOntologyBiologicalProcess | ketone catabolic process | 1.42e-04 | 21 | 101 | 3 | GO:0042182 | |
| GeneOntologyBiologicalProcess | phosphatidylinositol-3-phosphate biosynthetic process | 1.64e-04 | 22 | 101 | 3 | GO:0036092 | |
| GeneOntologyBiologicalProcess | epoxygenase P450 pathway | 1.64e-04 | 22 | 101 | 3 | GO:0019373 | |
| GeneOntologyBiologicalProcess | TOR signaling | 2.67e-04 | 181 | 101 | 6 | GO:0031929 | |
| GeneOntologyBiologicalProcess | small GTPase-mediated signal transduction | DOCK3 LPAR4 KBTBD6 RALGAPA2 ARHGEF25 ECT2 KBTBD7 CSNK1A1L ICMT CSNK1A1 | 3.08e-04 | 538 | 101 | 10 | GO:0007264 |
| GeneOntologyBiologicalProcess | regulation of branching involved in prostate gland morphogenesis | 3.52e-04 | 6 | 101 | 2 | GO:0060687 | |
| GeneOntologyBiologicalProcess | vitamin E metabolic process | 3.52e-04 | 6 | 101 | 2 | GO:0042360 | |
| GeneOntologyBiologicalProcess | organic hydroxy compound catabolic process | 4.55e-04 | 73 | 101 | 4 | GO:1901616 | |
| GeneOntologyBiologicalProcess | xenobiotic metabolic process | 6.51e-04 | 141 | 101 | 5 | GO:0006805 | |
| GeneOntologyBiologicalProcess | fatty acid derivative metabolic process | 7.07e-04 | 82 | 101 | 4 | GO:1901568 | |
| Domain | Cyt_P450_E_grp-I | 4.20e-09 | 45 | 101 | 7 | IPR002401 | |
| Domain | Cyt_P450_CS | 1.38e-08 | 53 | 101 | 7 | IPR017972 | |
| Domain | CYTOCHROME_P450 | 2.32e-08 | 57 | 101 | 7 | PS00086 | |
| Domain | p450 | 2.63e-08 | 58 | 101 | 7 | PF00067 | |
| Domain | Cyt_P450 | 3.35e-08 | 60 | 101 | 7 | IPR001128 | |
| Domain | - | 6.94e-07 | 58 | 101 | 6 | 1.10.630.10 | |
| Domain | MOZART2 | 2.90e-05 | 2 | 101 | 2 | IPR024332 | |
| Domain | MOZART2 | 2.90e-05 | 2 | 101 | 2 | PF12926 | |
| Domain | ARM-type_fold | 9.27e-05 | 339 | 101 | 9 | IPR016024 | |
| Domain | Myosin-like_IQ_dom | 1.40e-04 | 19 | 101 | 3 | IPR027401 | |
| Domain | - | 1.40e-04 | 19 | 101 | 3 | 4.10.270.10 | |
| Domain | U2AF_small | 2.86e-04 | 5 | 101 | 2 | IPR009145 | |
| Domain | LisH | 1.02e-03 | 9 | 101 | 2 | PF08513 | |
| Domain | AAA | 2.80e-03 | 52 | 101 | 3 | PF00004 | |
| Domain | Myosin_N | 2.90e-03 | 15 | 101 | 2 | PF02736 | |
| Domain | Myosin_N | 2.90e-03 | 15 | 101 | 2 | IPR004009 | |
| Domain | PI3/4_kinase_CS | 2.90e-03 | 15 | 101 | 2 | IPR018936 | |
| Domain | ATPase_AAA_core | 3.12e-03 | 54 | 101 | 3 | IPR003959 | |
| Domain | 7TM_GPCR_Srsx | 3.20e-03 | 112 | 101 | 4 | SM01381 | |
| Domain | - | 3.31e-03 | 16 | 101 | 2 | 1.10.1070.11 | |
| Domain | PI3Kc | 3.31e-03 | 16 | 101 | 2 | SM00146 | |
| Domain | PI3/4_kinase_cat_dom | 4.19e-03 | 18 | 101 | 2 | IPR000403 | |
| Domain | Myosin_tail_1 | 4.19e-03 | 18 | 101 | 2 | PF01576 | |
| Domain | ATP_grasp_subdomain_1 | 4.19e-03 | 18 | 101 | 2 | IPR013815 | |
| Domain | Myosin_tail | 4.19e-03 | 18 | 101 | 2 | IPR002928 | |
| Domain | PI3_PI4_kinase | 4.19e-03 | 18 | 101 | 2 | PF00454 | |
| Domain | PI3_4_KINASE_3 | 4.19e-03 | 18 | 101 | 2 | PS50290 | |
| Domain | PI3_4_KINASE_1 | 4.19e-03 | 18 | 101 | 2 | PS00915 | |
| Domain | PI3_4_KINASE_2 | 4.19e-03 | 18 | 101 | 2 | PS00916 | |
| Domain | GST_N | 6.23e-03 | 22 | 101 | 2 | PF02798 | |
| Domain | GST_NTER | 6.23e-03 | 22 | 101 | 2 | PS50404 | |
| Pathway | REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE | 3.14e-09 | 64 | 82 | 8 | M5650 | |
| Pathway | REACTOME_EICOSANOIDS | 4.51e-09 | 12 | 82 | 5 | M27129 | |
| Pathway | REACTOME_EICOSANOIDS | 4.51e-09 | 12 | 82 | 5 | MM14845 | |
| Pathway | WP_EICOSANOID_METABOLISM_VIA_CYTOCHROME_P450_MONOOXYGENASES | 1.13e-08 | 14 | 82 | 5 | MM15842 | |
| Pathway | REACTOME_FATTY_ACIDS | 1.69e-08 | 15 | 82 | 5 | M27126 | |
| Pathway | REACTOME_MISCELLANEOUS_SUBSTRATES | 4.75e-08 | 18 | 82 | 5 | MM14843 | |
| Pathway | REACTOME_FATTY_ACIDS | 4.75e-08 | 18 | 82 | 5 | MM14841 | |
| Pathway | WP_OXIDATION_BY_CYTOCHROME_P450 | 6.60e-08 | 62 | 82 | 7 | M39653 | |
| Pathway | REACTOME_PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS | 1.52e-07 | 104 | 82 | 8 | M738 | |
| Pathway | REACTOME_SYNTHESIS_OF_LEUKOTRIENES_LT_AND_EOXINS_EX | 2.85e-07 | 25 | 82 | 5 | MM14858 | |
| Pathway | REACTOME_MISCELLANEOUS_SUBSTRATES | 5.08e-07 | 12 | 82 | 4 | M27128 | |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | CYP3A7 CYP2C18 CYP4B1 CYP4F2 RXRA GSTM2 UGT2A3 CYP4F3 CYP4F12 CYP4F11 | 5.61e-07 | 220 | 82 | 10 | M10320 |
| Pathway | WP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II | CYP3A7 CYP2C18 CYP4B1 CYP4F2 GSTM2 UGT2A3 CYP4F3 CYP4F12 CYP4F11 | 1.12e-06 | 183 | 82 | 9 | M39588 |
| Pathway | WP_EICOSANOID_METABOLISM_VIA_CYCLOOXYGENASES_COX | 1.23e-06 | 33 | 82 | 5 | MM15918 | |
| Pathway | REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE | 2.21e-06 | 66 | 82 | 6 | MM14839 | |
| Pathway | REACTOME_SYNTHESIS_OF_LEUKOTRIENES_LT_AND_EOXINS_EX | 5.90e-06 | 21 | 82 | 4 | M27137 | |
| Pathway | WP_EICOSANOID_METABOLISM_VIA_CYTOCHROME_P450_MONOOXYGENASES_PATHWAY | 1.55e-05 | 9 | 82 | 3 | M39819 | |
| Pathway | REACTOME_ARACHIDONIC_ACID_METABOLISM | 2.71e-05 | 61 | 82 | 5 | MM14861 | |
| Pathway | REACTOME_SYNTHESIS_OF_16_20_HYDROXYEICOSATETRAENOIC_ACIDS_HETE | 3.03e-05 | 11 | 82 | 3 | MM14863 | |
| Pathway | REACTOME_PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS | 3.27e-05 | 105 | 82 | 6 | MM14842 | |
| Pathway | WP_EICOSANOID_METABOLISM_VIA_LIPOXYGENASES_LOX | 3.83e-05 | 33 | 82 | 4 | MM15963 | |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | 3.97e-05 | 219 | 82 | 8 | MM14838 | |
| Pathway | REACTOME_FATTY_ACID_METABOLISM | 5.83e-05 | 170 | 82 | 7 | MM15573 | |
| Pathway | WP_TRYPTOPHAN_METABOLISM | 1.70e-04 | 48 | 82 | 4 | MM15902 | |
| Pathway | KEGG_ARACHIDONIC_ACID_METABOLISM | 3.55e-04 | 58 | 82 | 4 | M5410 | |
| Pathway | REACTOME_ARACHIDONIC_ACID_METABOLISM | 3.79e-04 | 59 | 82 | 4 | M27140 | |
| Pathway | REACTOME_FATTY_ACID_METABOLISM | 5.56e-04 | 176 | 82 | 6 | M27854 | |
| Pathway | KEGG_LINOLEIC_ACID_METABOLISM | 6.21e-04 | 29 | 82 | 3 | M2920 | |
| Pathway | KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450 | 7.28e-04 | 70 | 82 | 4 | M16794 | |
| Pathway | WP_EICOSANOID_METABOLISM_VIA_CYCLOOXYGENASES_COX | 7.58e-04 | 31 | 82 | 3 | M39851 | |
| Pathway | KEGG_DRUG_METABOLISM_CYTOCHROME_P450 | 8.10e-04 | 72 | 82 | 4 | M9257 | |
| Pathway | WP_PREGNANE_X_RECEPTOR_PATHWAY | 8.33e-04 | 32 | 82 | 3 | M39567 | |
| Pathway | REACTOME_METABOLISM_OF_LIPIDS | ACACB CYP4B1 CYP4F2 OCRL SLC44A4 RXRA PIK3C2B PLA2G6 CYP4F3 CYP4F12 CYP4F11 | 8.91e-04 | 620 | 82 | 11 | MM15193 |
| Pathway | REACTOME_DEFECTIVE_CHSY1_CAUSES_TPBS | 9.15e-04 | 8 | 82 | 2 | M27261 | |
| Pathway | WP_INFLUENCE_OF_LAMINOPATHIES_ON_WNT_SIGNALING | 1.28e-03 | 37 | 82 | 3 | M39817 | |
| Pubmed | Omega oxidation of 3-hydroxy fatty acids by the human CYP4F gene subfamily enzyme CYP4F11. | 7.25e-11 | 4 | 103 | 4 | 18065749 | |
| Pubmed | 1.08e-09 | 6 | 103 | 4 | 9068972 | ||
| Pubmed | 1.67e-09 | 70 | 103 | 7 | 15128046 | ||
| Pubmed | 1.01e-07 | 4 | 103 | 3 | 22665481 | ||
| Pubmed | Expression and catalytic activity of mouse leukotriene B4 omega-hydroxylase, CYP4F14. | 1.01e-07 | 4 | 103 | 3 | 11185557 | |
| Pubmed | 2.51e-07 | 5 | 103 | 3 | 22969154 | ||
| Pubmed | Cytochrome P4504f, a potential therapeutic target limiting neuroinflammation. | 2.51e-07 | 5 | 103 | 3 | 21466787 | |
| Pubmed | 8.75e-07 | 7 | 103 | 3 | 22160543 | ||
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | TANC2 GRK5 USP24 RPL14 CSNK1A1L CSNK1A1 PKM MZT2A MZT2B HSPA4 | 1.56e-06 | 475 | 103 | 10 | 31040226 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | TANC2 DOCK3 COL4A5 RANBP10 SPG7 GRK5 CHSY1 HUWE1 MLXIP RALGAPA2 PIK3C2B PLA2G6 ZFYVE26 TANC1 | 4.88e-06 | 1105 | 103 | 14 | 35748872 |
| Pubmed | Identification of atrogin-1-targeted proteins during the myostatin-induced skeletal muscle wasting. | 7.12e-06 | 155 | 103 | 6 | 22673621 | |
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 15131121 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 37075701 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 23354688 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 33691379 | ||
| Pubmed | Tissue-specific distribution of mouse casein kinase I alpha mRNA. | 8.69e-06 | 2 | 103 | 2 | 9522121 | |
| Pubmed | CSNK1A1/CK1α suppresses autoimmunity by restraining the CGAS-STING1 signaling. | 8.69e-06 | 2 | 103 | 2 | 37723657 | |
| Pubmed | Casein Kinase 1α Regulates Testosterone Synthesis and Testis Development in Adult Mice. | 8.69e-06 | 2 | 103 | 2 | 36929849 | |
| Pubmed | ATM regulates Cdt1 stability during the unperturbed S phase to prevent re-replication. | 8.69e-06 | 2 | 103 | 2 | 24280901 | |
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 35695793 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 24471565 | ||
| Pubmed | Exploring the role of casein kinase 1α splice variants across cancer cell lines. | 8.69e-06 | 2 | 103 | 2 | 38852281 | |
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 23690993 | ||
| Pubmed | Knockdown of Csnk1a1 results in preimplantation developmental arrest in mice. | 8.69e-06 | 2 | 103 | 2 | 36542875 | |
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 24138531 | ||
| Pubmed | Expression of CYP4F2 in human liver and kidney: assessment using targeted peptide antibodies. | 8.69e-06 | 2 | 103 | 2 | 18662666 | |
| Pubmed | Expression and physiological function of CYP4F subfamily in human eosinophils. | 8.69e-06 | 2 | 103 | 2 | 17980168 | |
| Pubmed | Cloning and expression of a novel form of leukotriene B4 omega-hydroxylase from human liver. | 8.69e-06 | 2 | 103 | 2 | 8026587 | |
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 18000302 | ||
| Pubmed | Drosophila glucome screening identifies Ck1alpha as a regulator of mammalian glucose metabolism. | 8.69e-06 | 2 | 103 | 2 | 25994086 | |
| Pubmed | Zrsr2 and functional U12-dependent spliceosome are necessary for follicular development. | 8.69e-06 | 2 | 103 | 2 | 35198906 | |
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 15364545 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 34216174 | ||
| Pubmed | Casein Kinase 1α as a Novel Factor Affects Thyrotropin Synthesis via PKC/ERK/CREB Signaling. | 8.69e-06 | 2 | 103 | 2 | 37108197 | |
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 21068316 | ||
| Pubmed | Comparative expression profiling of 40 mouse cytochrome P450 genes in embryonic and adult tissues. | 8.99e-06 | 44 | 103 | 4 | 12745259 | |
| Pubmed | 1.50e-05 | 50 | 103 | 4 | 23703321 | ||
| Pubmed | 1.66e-05 | 17 | 103 | 3 | 20395553 | ||
| Pubmed | MYH3 MYH11 ACACB TTC16 PCDHGA7 GRK5 ATP10B RPL14 RNF17 MYLK2 TBC1D31 ASPM PKM UGGT2 ATM | 2.27e-05 | 1442 | 103 | 15 | 35575683 | |
| Pubmed | 2.60e-05 | 3 | 103 | 2 | 27600268 | ||
| Pubmed | Isolation and mapping of human homologues of an imprinted mouse gene U2af1-rs1. | 2.60e-05 | 3 | 103 | 2 | 8586425 | |
| Pubmed | Tanc1/2 TPR domain interacts with Myo18a C-terminus and undergoes liquid-liquid phase separation. | 2.60e-05 | 3 | 103 | 2 | 38092135 | |
| Pubmed | Human CYP4F3s are the main catalysts in the oxidation of fatty acid epoxides. | 2.60e-05 | 3 | 103 | 2 | 15145985 | |
| Pubmed | MZT Proteins Form Multi-Faceted Structural Modules in the γ-Tubulin Ring Complex. | 2.60e-05 | 3 | 103 | 2 | 32610146 | |
| Pubmed | 2.60e-05 | 3 | 103 | 2 | 27323688 | ||
| Pubmed | Csnk1a1 inhibition has p53-dependent therapeutic efficacy in acute myeloid leukemia. | 2.60e-05 | 3 | 103 | 2 | 24616378 | |
| Pubmed | Role of casein kinase 1A1 in the biology and targeted therapy of del(5q) MDS. | 2.60e-05 | 3 | 103 | 2 | 25242043 | |
| Pubmed | 2.60e-05 | 3 | 103 | 2 | 28655862 | ||
| Pubmed | 2.60e-05 | 3 | 103 | 2 | 34909679 | ||
| Pubmed | 2.60e-05 | 3 | 103 | 2 | 27686097 | ||
| Pubmed | The KBTBD6/7-DRD2 axis regulates pituitary adenoma sensitivity to dopamine agonist treatment. | 2.60e-05 | 3 | 103 | 2 | 32572597 | |
| Pubmed | CK1α ablation in keratinocytes induces p53-dependent, sunburn-protective skin hyperpigmentation. | 2.60e-05 | 3 | 103 | 2 | 28878021 | |
| Pubmed | Type I Interferons Control Proliferation and Function of the Intestinal Epithelium. | 2.60e-05 | 3 | 103 | 2 | 26811327 | |
| Pubmed | Concurrent Zrsr2 mutation and Tet2 loss promote myelodysplastic neoplasm in mice. | 2.60e-05 | 3 | 103 | 2 | 36030305 | |
| Pubmed | 2.60e-05 | 3 | 103 | 2 | 19805514 | ||
| Pubmed | 2.60e-05 | 3 | 103 | 2 | 23333640 | ||
| Pubmed | 3.23e-05 | 21 | 103 | 3 | 23428871 | ||
| Pubmed | UBXD7 binds multiple ubiquitin ligases and implicates p97 in HIF1alpha turnover. | 3.55e-05 | 62 | 103 | 4 | 18775313 | |
| Pubmed | Detection of cytochrome P450 gene expression in human placenta in first trimester of pregnancy. | 5.19e-05 | 4 | 103 | 2 | 8694864 | |
| Pubmed | 5.19e-05 | 4 | 103 | 2 | 9001233 | ||
| Pubmed | 5.19e-05 | 4 | 103 | 2 | 21503962 | ||
| Pubmed | The gut microbiome switches mutant p53 from tumour-suppressive to oncogenic. | 5.19e-05 | 4 | 103 | 2 | 32728212 | |
| Pubmed | RIP-140 interacts with multiple nuclear receptors by means of two distinct sites. | 5.19e-05 | 4 | 103 | 2 | 8887632 | |
| Pubmed | An orphan nuclear receptor activated by pregnanes defines a novel steroid signaling pathway. | 5.19e-05 | 4 | 103 | 2 | 9489701 | |
| Pubmed | 5.19e-05 | 4 | 103 | 2 | 26711340 | ||
| Pubmed | 5.19e-05 | 4 | 103 | 2 | 7558001 | ||
| Pubmed | Regulation of p53-MDMX interaction by casein kinase 1 alpha. | 5.19e-05 | 4 | 103 | 2 | 16024788 | |
| Pubmed | 5.19e-05 | 4 | 103 | 2 | 21298030 | ||
| Pubmed | 5.19e-05 | 4 | 103 | 2 | 30487124 | ||
| Pubmed | 5.19e-05 | 4 | 103 | 2 | 21397694 | ||
| Pubmed | 5.19e-05 | 4 | 103 | 2 | 38147624 | ||
| Pubmed | 5.19e-05 | 4 | 103 | 2 | 18784308 | ||
| Pubmed | FAM83D directs protein kinase CK1α to the mitotic spindle for proper spindle positioning. | 5.19e-05 | 4 | 103 | 2 | 31338967 | |
| Pubmed | 5.19e-05 | 4 | 103 | 2 | 10768437 | ||
| Pubmed | 5.19e-05 | 4 | 103 | 2 | 17595322 | ||
| Pubmed | Cx43 phosphorylation sites regulate pancreatic cancer metastasis. | 5.19e-05 | 4 | 103 | 2 | 33603164 | |
| Pubmed | The E3 ubiquitin ligase Mule acts through the ATM-p53 axis to maintain B lymphocyte homeostasis. | 5.19e-05 | 4 | 103 | 2 | 22213803 | |
| Pubmed | 5.19e-05 | 4 | 103 | 2 | 11875057 | ||
| Pubmed | 8.64e-05 | 5 | 103 | 2 | 19776272 | ||
| Pubmed | 8.64e-05 | 5 | 103 | 2 | 36989576 | ||
| Pubmed | CKIα ablation highlights a critical role for p53 in invasiveness control. | 8.64e-05 | 5 | 103 | 2 | 21331045 | |
| Pubmed | MOZ-TIF2 inhibits transcription by nuclear receptors and p53 by impairment of CBP function. | 8.64e-05 | 5 | 103 | 2 | 15657427 | |
| Pubmed | Ser-884 adjacent to the LXXLL motif of coactivator TRBP defines selectivity for ERs and TRs. | 8.64e-05 | 5 | 103 | 2 | 11773444 | |
| Pubmed | 8.64e-05 | 5 | 103 | 2 | 11093772 | ||
| Pubmed | 8.64e-05 | 5 | 103 | 2 | 18577768 | ||
| Pubmed | Phosphorylation of FADD by the kinase CK1α promotes KRASG12D-induced lung cancer. | 8.64e-05 | 5 | 103 | 2 | 25628462 | |
| Pubmed | 8.64e-05 | 5 | 103 | 2 | 9628876 | ||
| Pubmed | Crbn I391V is sufficient to confer in vivo sensitivity to thalidomide and its derivatives in mice. | 8.64e-05 | 5 | 103 | 2 | 30064974 | |
| Pubmed | A senescence-inflammatory switch from cancer-inhibitory to cancer-promoting mechanism. | 8.64e-05 | 5 | 103 | 2 | 23890787 | |
| Pubmed | 8.64e-05 | 5 | 103 | 2 | 37944068 | ||
| Pubmed | 8.64e-05 | 5 | 103 | 2 | 30651631 | ||
| Pubmed | 8.64e-05 | 5 | 103 | 2 | 37257767 | ||
| Pubmed | 8.64e-05 | 5 | 103 | 2 | 27481942 | ||
| Pubmed | ERBP, a novel estrogen receptor binding protein enhancing the activity of estrogen receptor. | 8.64e-05 | 5 | 103 | 2 | 15047147 | |
| Pubmed | 9.66e-05 | 30 | 103 | 3 | 20301299 | ||
| Pubmed | Transcriptome analysis of mouse stem cells and early embryos. | 1.07e-04 | 363 | 103 | 7 | 14691545 | |
| Pubmed | Ubiquitin-assisted phase separation of dishevelled-2 promotes Wnt signalling. | 1.21e-04 | 161 | 103 | 5 | 36398662 | |
| Pubmed | The complexity of p53 modulation: emerging patterns from divergent signals. | 1.29e-04 | 6 | 103 | 2 | 9765199 | |
| Pubmed | 1.29e-04 | 6 | 103 | 2 | 9430642 | ||
| Pubmed | Casein kinase I and casein kinase II differentially regulate axin function in Wnt and JNK pathways. | 1.29e-04 | 6 | 103 | 2 | 11884395 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr15q26 | 1.06e-04 | 206 | 103 | 5 | chr15q26 | |
| GeneFamily | Cytochrome P450 family 4 | 3.91e-07 | 36 | 76 | 5 | 1003 | |
| GeneFamily | AAA ATPases | 1.44e-03 | 53 | 76 | 3 | 413 | |
| GeneFamily | Myosin heavy chains | 1.77e-03 | 15 | 76 | 2 | 1098 | |
| Coexpression | SAENZ_DETOX_PATHWAY_AND_CARCINOGENESIS_DN | 9.60e-07 | 20 | 101 | 4 | MM1104 | |
| Coexpression | SAENZ_DETOX_PATHWAY_AND_CARCINOGENESIS_DN | 2.44e-05 | 15 | 101 | 3 | M1141 | |
| Coexpression | CAIRO_HEPATOBLASTOMA_CLASSES_UP | USP24 RPL14 HUWE1 ECT2 TBC1D31 FAM136A ASPM UTP20 UGGT2 CDT1 CTSV | 2.44e-05 | 612 | 101 | 11 | M4772 |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.20e-08 | 185 | 103 | 8 | efc5d564f8793c751ba640aef60f761e4b081d3f | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Oligo-OPC|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.20e-08 | 185 | 103 | 8 | fba2dc46cd98ab9c78e788959c2121aa10d148b2 | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.81e-07 | 188 | 103 | 7 | b382d18fb09fb2869f3c151efa71540a7f5ed229 | |
| ToppCell | MS-CD8-memory_CD4|MS / Condition, Cell_class and T cell subcluster | 1.59e-06 | 154 | 103 | 6 | aec893cf3e1cf90e18a9117183fc7a1f397425a9 | |
| ToppCell | LPS-antiTNF-Endothelial-Mes-Like|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.84e-06 | 158 | 103 | 6 | 50df52d64d07178975563abd98ce4fddb9f2f7ef | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Oligo-OPC|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.17e-06 | 182 | 103 | 6 | 8a8b08ac4bb3cba3541dbe234e088703842285b9 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.17e-06 | 182 | 103 | 6 | e36766309c4d96a90d213ce37d3acef1029a3fdc | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.58e-06 | 185 | 103 | 6 | 2e1766f1a972fecd670daaaf7eb2d3a404f121e7 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Oligo-OPC|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.58e-06 | 185 | 103 | 6 | 7aaa8335b40927e3e8fdcede807cd521fc213a0d | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_NK-NK_CD56bright_CD16-|bone_marrow / Manually curated celltypes from each tissue | 6.01e-06 | 194 | 103 | 6 | 5c58a2d1dd3c8ff77ce44d473239685e6b020909 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.37e-06 | 196 | 103 | 6 | f374cb3ec31c6eef2cef9e07547bfd1e380553af | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.37e-06 | 196 | 103 | 6 | 671c380b58d7f634b4fbec38c357d357ea4f3535 | |
| ToppCell | 10x5'-Liver-Lymphocytic_NK-NK_CD56bright_CD16-|Liver / Manually curated celltypes from each tissue | 6.37e-06 | 196 | 103 | 6 | 4ad73515af265432235b698fceb0ba370ced3e52 | |
| ToppCell | Sepsis-ICU-NoSEP-Lymphocyte-T/NK-CD8+_Tcm|ICU-NoSEP / Disease, condition lineage and cell class | 6.95e-06 | 199 | 103 | 6 | 1df6d3dfb90e804cf65dc4dcb1c51d5974abfbab | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.95e-06 | 199 | 103 | 6 | 19a97e27a4758e794ce7246d295e112b47931a48 | |
| ToppCell | (1)_T_cell-(18)_cycling_gd_T|(1)_T_cell / shred on Cell_type and subtype | 6.95e-06 | 199 | 103 | 6 | 9369d0e4efe809e3e8757294ebebba5a47b30528 | |
| ToppCell | mLN-T_cell-cycling_gd_T|mLN / Region, Cell class and subclass | 7.15e-06 | 200 | 103 | 6 | 4efeef51f885ee8f6dd3911a536cc49e3c14da98 | |
| ToppCell | mLN-(1)_T_cell-(18)_cycling_gd_T|mLN / shred on region, Cell_type, and subtype | 7.15e-06 | 200 | 103 | 6 | e8a0a88a8344e80783931115bbe6cd5b62a4c1f7 | |
| ToppCell | Sigmoid-(1)_T_cell-(18)_cycling_gd_T|Sigmoid / shred on region, Cell_type, and subtype | 7.15e-06 | 200 | 103 | 6 | 6e367abd1a4b87e20eb9095b8337723163e8bbae | |
| ToppCell | Sigmoid-T_cell-cycling_gd_T|Sigmoid / Region, Cell class and subclass | 7.15e-06 | 200 | 103 | 6 | 9769185abae084ffac36420c749625e679b70ca8 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Epi-like-Gen_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.99e-05 | 142 | 103 | 5 | d52da766e031f7409eb5a7a9fa88f48e14a79d8b | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Epi-like|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.99e-05 | 142 | 103 | 5 | a05b320cf182b2aaf18df7c40045dc65b659bf20 | |
| ToppCell | ICU-NoSEP-Lymphocyte-T_NK-CD8_TCM|ICU-NoSEP / Disease, Lineage and Cell Type | 3.53e-05 | 160 | 103 | 5 | a1bf6ed365cbc1ddb57c132a42dbe6485d45f544 | |
| ToppCell | 10x5'-blood-Lymphocytic_NK-NK_CD56bright_CD16-|blood / Manually curated celltypes from each tissue | 4.21e-05 | 166 | 103 | 5 | ba42349a68b22e91a0340bda1ccecd6c7592392f | |
| ToppCell | Entopeduncular-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Tgfb2_(Tgfb2)--|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 4.34e-05 | 84 | 103 | 4 | 43e77117579290446a7e386c0be3459d652d9384 | |
| ToppCell | Entopeduncular-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Tgfb2_(Tgfb2)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 4.34e-05 | 84 | 103 | 4 | 38a457a20701fe23c6326b7282cd0993cdd87082 | |
| ToppCell | Entopeduncular-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Tgfb2_(Tgfb2)-|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 4.34e-05 | 84 | 103 | 4 | 59d0415bb6b6b18a94d2c9c6289fa9cbcb2166e3 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.12e-05 | 173 | 103 | 5 | 4bc6d93716f093b460c8b047199db8cab5fea720 | |
| ToppCell | facs-Skin-Anagen-24m-Epithelial-actively_dividing_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.71e-05 | 177 | 103 | 5 | 8a0f0fbb06cdacb99a3fdba0da3e0494b891db4f | |
| ToppCell | facs-Skin-Anagen-24m-Epithelial-keratinocyte_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.71e-05 | 177 | 103 | 5 | e9d7682517fb30fd2ad535d59779d718a7024c13 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-FOXM1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.18e-05 | 180 | 103 | 5 | 334e2b1f6eb7d4ece20b1c7b02107863f913237f | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-OPC-like-OPC-like_Prolif-B|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.34e-05 | 181 | 103 | 5 | c1fad1f03468523e563c039be520dcf7717f90cd | |
| ToppCell | 10x5'-bone_marrow-Mast-Mast_cell_lympho|bone_marrow / Manually curated celltypes from each tissue | 6.34e-05 | 181 | 103 | 5 | 56fa77ae31f3b7de6e441a439c33a11353b6573a | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.51e-05 | 182 | 103 | 5 | a05e5978ef5f7fac7eeb2ba1c0103ea90d5e9136 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Oligo-OPC|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.51e-05 | 182 | 103 | 5 | 831b5ce46b41efe01c4db6016c2f43148611373d | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Oligo-OPC|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.51e-05 | 182 | 103 | 5 | 3cc61f5f7ad4a81eba3daf65e122880b5af3adc0 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.51e-05 | 182 | 103 | 5 | 5d909e4b5f662905bf1be9c686bbddc3e87d2be9 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c11-MKI67-FOS|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.68e-05 | 183 | 103 | 5 | ba7753e9fe2a6a87c5264f299ac97da2ddbda178 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.86e-05 | 184 | 103 | 5 | a8c6028d745aaa6ee7842259238694cb50ce0526 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil-Neu_4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.86e-05 | 184 | 103 | 5 | 081d045f3bc98a36f342de7d50f39c9a888dd7eb | |
| ToppCell | Control-Myeloid_G-immature_Neutrophil|Control / Disease group, lineage and cell class | 6.86e-05 | 184 | 103 | 5 | 45f873236f7e90fb78c8e291d3b5b92d121acec9 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.86e-05 | 184 | 103 | 5 | 84c20730cd92b9aaa50077d7b625e37e7f9e91d2 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil-Neu_4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.86e-05 | 184 | 103 | 5 | d31d4116d1d196633784863781fa45673607a421 | |
| ToppCell | Control-immature_Neutrophil-|Control / Disease condition and Cell class | 6.86e-05 | 184 | 103 | 5 | c4e8ba82a6aa76c46f05a71d5f1c7926555318cf | |
| ToppCell | Control-immature_Neutrophil|Control / Disease condition and Cell class | 6.86e-05 | 184 | 103 | 5 | 2fdae5c6b3eb2232881d933a8c1061fda3623016 | |
| ToppCell | Control-Lymphoid-ILC_A|Lymphoid / Disease state, Lineage and Cell class | 7.04e-05 | 185 | 103 | 5 | 520795866d44def5be3910ce8e728045c716a24d | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1|Adult / Lineage, Cell type, age group and donor | 7.40e-05 | 187 | 103 | 5 | 77f78aec946bc6bd85c29aee9ca978ce49f853a3 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.59e-05 | 188 | 103 | 5 | b2d68a32314e9b099ed74d974079ad96359d1ae3 | |
| ToppCell | Smart-seq2-bone_marrow_(Smart-seq2)|Smart-seq2 / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 7.59e-05 | 188 | 103 | 5 | 557a0ac069a6ff4e687cac032f64170b9b247165 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-B_(AT2)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 7.62e-05 | 97 | 103 | 4 | eab10b1af9cd0ce373cd4d0316e0d7b218630584 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-B_(AT2)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 7.62e-05 | 97 | 103 | 4 | 04f571708f2487b0dbd70ee507de6bf75be5f5d9 | |
| ToppCell | 3'-Adult-Distal_Rectal-Mesenchymal-Pericytes|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.78e-05 | 189 | 103 | 5 | d69b7a01dd4d6ad043bb6210e9ab34b49578389c | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.78e-05 | 189 | 103 | 5 | 977a813e5d7a5a561c1fced2bbf21c20056b88d8 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.78e-05 | 189 | 103 | 5 | 127ad2ba3e794df8cce2eee3e4171bccb5aad51b | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.78e-05 | 189 | 103 | 5 | 2cfb4d12f75678d1619f4743838a0e954bd57761 | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_NK-NK_CD56bright_CD16-|bone_marrow / Manually curated celltypes from each tissue | 7.78e-05 | 189 | 103 | 5 | 6e402fb3fc31e4cb541e3cd140d7a86c1083dbf5 | |
| ToppCell | 3'-Adult-Distal_Rectal-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.78e-05 | 189 | 103 | 5 | 2b5f1b4f173a224342ea4f10b193ee33b7662699 | |
| ToppCell | 3'-Adult-Distal_Rectal-Mesenchymal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.78e-05 | 189 | 103 | 5 | 43e131458d8a4b120f7a5fb3d0c5650abded15f6 | |
| ToppCell | Control-Endothelial-VE_Venous|Endothelial / Disease state, Lineage and Cell class | 7.98e-05 | 190 | 103 | 5 | 4e30155203b4a8c5e496fcbe9348b67b98ebc625 | |
| ToppCell | ILEUM-non-inflamed-(8)_Activated_fibroblasts|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 7.98e-05 | 190 | 103 | 5 | 39fa110d19c97c7cac99f5fb91b26bc08e2f3b42 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.98e-05 | 190 | 103 | 5 | e252e925600e6457fa6e362a55217f4cffa75cdb | |
| ToppCell | E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal|E16.5-samps / Age Group, Lineage, Cell class and subclass | 8.18e-05 | 191 | 103 | 5 | 3379d145d34f89150f7b06d1340022cfc6b4a6ce | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)|10x_3'_v3 / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 8.38e-05 | 192 | 103 | 5 | 072281344d58e85c9a290750b488d0c101f75d54 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.59e-05 | 193 | 103 | 5 | 826b8dd801298b3e0cd76232feae5a14026b8806 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.59e-05 | 193 | 103 | 5 | 87d3a577d37fb0cb4b6313c596310de452bc3872 | |
| ToppCell | ILEUM-inflamed-(8)_Smooth_muscle_cells|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 8.59e-05 | 193 | 103 | 5 | 084c88f08ce0ecd6c9f4334caed370eb2154f896 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.59e-05 | 193 | 103 | 5 | d485634c564b268e344b6a2863c26f6adaec9e38 | |
| ToppCell | Control-NK_CD56bright|Control / Disease condition and Cell class | 8.59e-05 | 193 | 103 | 5 | 8b1e7a226a6057e1097c1525984127b54e823876 | |
| ToppCell | (4)_Endothelial_cells-(42)_EC-sinusoidal|(4)_Endothelial_cells / Cell class and subclass of bone marrow stroma cells in homeostatis | 8.80e-05 | 194 | 103 | 5 | 4199900d16623eca02d674d5ada7f0989e47955e | |
| ToppCell | Basal-basal-1|World / Class top | 8.80e-05 | 194 | 103 | 5 | b870f2d856e08c5c3596ca9da538eb8c93a7c062 | |
| ToppCell | IPF-Endothelial-VE_Venous|Endothelial / Disease state, Lineage and Cell class | 8.80e-05 | 194 | 103 | 5 | e8a9005963704286bcc50785bda8d7d63ec001b1 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_NK-NK_CD56bright_CD16-|lymph-node_spleen / Manually curated celltypes from each tissue | 8.80e-05 | 194 | 103 | 5 | 8a596f25f6bfa5baaa2f52d80ad92f2925713398 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.01e-05 | 195 | 103 | 5 | d8ebb94f30d4a655d6b29dd6a3076be2403d2356 | |
| ToppCell | Cerebellum-Endothelial|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 9.01e-05 | 195 | 103 | 5 | 2192fd9b4682054776f0716933aed5a4a9412657 | |
| ToppCell | tumor_Lung-Fibroblasts-Smooth_muscle_cells|tumor_Lung / Location, Cell class and cell subclass | 9.01e-05 | 195 | 103 | 5 | ea9ff25020c2fcd1bab80e1829af0f4e4777de8b | |
| ToppCell | 356C-Fibroblasts-Fibroblast-K_(Pericytes)|356C / Donor, Lineage, Cell class and subclass (all cells) | 9.23e-05 | 196 | 103 | 5 | a5cc4f76e1a3825aaccba9a686d7da6f7e4300ff | |
| ToppCell | 356C-Fibroblasts-Fibroblast-K_(Pericytes)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 9.23e-05 | 196 | 103 | 5 | 476812fc1422aca8010d771eff11fa6081f15a2d | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.23e-05 | 196 | 103 | 5 | db64ab27374f82553ee577aec056141170f3656f | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.46e-05 | 197 | 103 | 5 | d9e196c8b4a6ede4733946dbdba3331534954beb | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.69e-05 | 198 | 103 | 5 | 09be07ebfc3e49c3858e9b74605b69cf4fc28b56 | |
| ToppCell | NS-critical-d_07-13|critical / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 9.69e-05 | 198 | 103 | 5 | a6e11c87b31beffb6af190c64b4ef3ee1d9dab8d | |
| ToppCell | Caecum-(1)_T_cell-(18)_cycling_gd_T|Caecum / shred on region, Cell_type, and subtype | 9.69e-05 | 198 | 103 | 5 | 64278d8831c81874937e76b561c53928dfc437c5 | |
| ToppCell | Caecum-T_cell-cycling_gd_T|Caecum / Region, Cell class and subclass | 9.69e-05 | 198 | 103 | 5 | 5b719b67f8384863077070e1eb7e04a320e6dab4 | |
| ToppCell | mLN-T_cell-cycling_gd_T|T_cell / Region, Cell class and subclass | 9.92e-05 | 199 | 103 | 5 | c81a194f8c2f120c6c4d74857912865a3c2fe1e7 | |
| ToppCell | Caecum-T_cell-cycling_gd_T|T_cell / Region, Cell class and subclass | 9.92e-05 | 199 | 103 | 5 | 64d1e495307a91bc012130613126d86e0cf170b0 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.92e-05 | 199 | 103 | 5 | 333056c2abe9724efeab542c0365fcfe4eff8f18 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 9.92e-05 | 199 | 103 | 5 | e9820d5fb4e8b46973c4c50ac5db8fb4a1bf603b | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.92e-05 | 199 | 103 | 5 | a697b3f0760e66bad8ea8d83cf6fea5934692c56 | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_secretory|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 9.92e-05 | 199 | 103 | 5 | 7223f853335492ca617dbec3e4b6872a8a463a45 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_secretory-Secretory_Goblet|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 9.92e-05 | 199 | 103 | 5 | 3c3133d0aa65338a576634def13e7f0f5c573a10 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.92e-05 | 199 | 103 | 5 | e60ecbb8fa7bcd3e2ce7d78f6efb2cfd1fd77698 | |
| ToppCell | ILEUM-non-inflamed-(8)_Smooth_muscle_cells|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 9.92e-05 | 199 | 103 | 5 | 3368c0a90a47c4dcdfe70be3192550df0744e508 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|Control_saline / Treatment groups by lineage, cell group, cell type | 1.02e-04 | 200 | 103 | 5 | c5e051f1aac8dda376c342a9932785a23450e073 | |
| ToppCell | proximal-mesenchymal-Vascular_Smooth_Muscle-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.02e-04 | 200 | 103 | 5 | 5c0135d3cb6f7fa904e9760904dfe5f11c7e9102 | |
| ToppCell | Control-Control-Myeloid-immature_Neutrophil|Control / Disease, condition lineage and cell class | 1.02e-04 | 200 | 103 | 5 | 118321ac443feb42aee171baccfc4610f00a8822 | |
| ToppCell | proximal-3-mesenchymal-Vascular_Smooth_Muscle|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.02e-04 | 200 | 103 | 5 | 870ab11343711f64fe6d6a858fc420fe17f1636a | |
| ToppCell | myeloid-pro-cDC|myeloid / Lineage and Cell class | 1.02e-04 | 200 | 103 | 5 | 4aa2308eeb94e0bdff4e02eb9e45ba8837ae14bf | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic|Control_saline / Treatment groups by lineage, cell group, cell type | 1.02e-04 | 200 | 103 | 5 | 9d5b3c2dcfa55d50acc2ce2c319d51aa525d4cd1 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.02e-04 | 200 | 103 | 5 | 87827041663013f5e7273168dc8709d69840e7ce | |
| ToppCell | Sigmoid-T_cell-cycling_gd_T|T_cell / Region, Cell class and subclass | 1.02e-04 | 200 | 103 | 5 | 4e489ecf472857357d45e9f6c7a812aa48b72ebf | |
| Computational | Cytochrome P450. | 8.39e-05 | 14 | 68 | 3 | MODULE_106 | |
| Drug | propoxyphene | 6.96e-10 | 67 | 103 | 8 | CID000010100 | |
| Drug | AC1L1KIN | 1.76e-08 | 100 | 103 | 8 | CID000005516 | |
| Drug | carteolol | 3.65e-08 | 72 | 103 | 7 | CID000002583 | |
| Drug | AC1Q7AUJ | 6.05e-08 | 117 | 103 | 8 | CID000003303 | |
| Drug | BP-7,8-diol | 6.40e-08 | 78 | 103 | 7 | CID000025892 | |
| Drug | C14802 | 6.84e-08 | 47 | 103 | 6 | CID011954053 | |
| Drug | benzphetamine | 6.90e-08 | 119 | 103 | 8 | CID000002341 | |
| Drug | felodipine | CYP3A7 CYP2C18 CYP4B1 ESR1 CYP4F2 MYLK2 CYP4F3 CYP4F12 CYP4F11 | 7.63e-08 | 169 | 103 | 9 | CID000003333 |
| Drug | trimipramine | 7.64e-08 | 80 | 103 | 7 | CID000005584 | |
| Drug | C14800 | 7.78e-08 | 48 | 103 | 6 | CID011954051 | |
| Drug | aminopyrine | CYP3A7 CYP2C18 CYP4B1 CYP4F2 PLAA UGT2A3 CYP4F3 CYP4F12 CYP4F11 | 8.44e-08 | 171 | 103 | 9 | CID000006009 |
| Drug | bromobenzene-3,4-oxide | 8.84e-08 | 49 | 103 | 6 | CID000108121 | |
| Drug | bromobenzene-2,3-oxide | 1.00e-07 | 50 | 103 | 6 | CID003036760 | |
| Drug | 1,1-dichloroethylene epoxide | 1.00e-07 | 50 | 103 | 6 | CID000119521 | |
| Drug | naphthalene epoxide | 1.13e-07 | 51 | 103 | 6 | CID000108063 | |
| Drug | hexobarbital | 1.15e-07 | 127 | 103 | 8 | CID000003608 | |
| Drug | diosmetin | 1.17e-07 | 85 | 103 | 7 | CID005281612 | |
| Drug | BP-9,10-oxide | 1.28e-07 | 27 | 103 | 5 | CID000037456 | |
| Drug | Brn 4136738 | 1.28e-07 | 27 | 103 | 5 | CID000050331 | |
| Drug | C14845 | 1.28e-07 | 27 | 103 | 5 | CID011954064 | |
| Drug | mephenytoin | 1.48e-07 | 88 | 103 | 7 | CID000004060 | |
| Drug | 9-OH-BaP-4,5-oxide | 1.55e-07 | 28 | 103 | 5 | CID000115064 | |
| Drug | dichloroacetaldehyde | 1.60e-07 | 54 | 103 | 6 | CID000006576 | |
| Drug | chloroacetyl chloride | 1.79e-07 | 55 | 103 | 6 | CID000006577 | |
| Drug | parathion | 1.87e-07 | 91 | 103 | 7 | CID000000991 | |
| Drug | aminoglutethimide | 2.06e-07 | 137 | 103 | 8 | CID000002145 | |
| Drug | tienilic acid | 2.17e-07 | 93 | 103 | 7 | CID000038409 | |
| Drug | lansoprazole | 2.17e-07 | 93 | 103 | 7 | CID000003883 | |
| Drug | 2-naphthol | 2.17e-07 | 93 | 103 | 7 | CID000008663 | |
| Drug | 19-hydroxytestosterone | 2.24e-07 | 30 | 103 | 5 | CID000150968 | |
| Drug | 11-H-14,15-EETA | 2.24e-07 | 30 | 103 | 5 | CID011954058 | |
| Drug | bromoacetaldehyde | 2.48e-07 | 58 | 103 | 6 | CID000105131 | |
| Drug | BP-7,8-oxide | 3.14e-07 | 32 | 103 | 5 | CID000037455 | |
| Drug | BP-4,5-oxide | 3.36e-07 | 61 | 103 | 6 | CID000037786 | |
| Drug | Sparteinum | 3.83e-07 | 101 | 103 | 7 | CID000003966 | |
| Drug | 12(13)-EpOME | 4.31e-07 | 34 | 103 | 5 | CID000001416 | |
| Drug | TCEO | 4.31e-07 | 34 | 103 | 5 | CID000028167 | |
| Drug | AC1O5XSP | 4.31e-07 | 34 | 103 | 5 | CID006442739 | |
| Drug | diclofenac | CYP3A7 CYP2C18 CYP4B1 USP24 CYP4F2 CYP4F3 CYP4F12 CYP4F11 EPAS1 | 4.64e-07 | 209 | 103 | 9 | CID000003032 |
| Drug | AC1L1CJI | 5.01e-07 | 35 | 103 | 5 | CID000001929 | |
| Drug | 15-H-11,12-EETA | 5.79e-07 | 36 | 103 | 5 | CID011954042 | |
| Drug | AC1L3NGJ | 5.79e-07 | 36 | 103 | 5 | CID000092121 | |
| Drug | phenobarbital | DOCK3 CYP3A7 CYP2C18 CYP4B1 CYP4F2 RXRA GSTM2 UGT2A3 CYP4F3 CYP4F12 CYP4F11 | 7.22e-07 | 360 | 103 | 11 | CID000004763 |
| Drug | paraoxon | 8.13e-07 | 164 | 103 | 8 | CID000009395 | |
| Drug | 1,2-dibromoethane | 8.35e-07 | 71 | 103 | 6 | CID000007839 | |
| Drug | 11,14,15-THET | 8.75e-07 | 39 | 103 | 5 | CID006439531 | |
| Drug | AC1O5PIQ | 8.75e-07 | 39 | 103 | 5 | CID006438348 | |
| Drug | 2,2,2-trichloroethanol | 9.85e-07 | 73 | 103 | 6 | CID000008259 | |
| Drug | 8-MOP | 1.10e-06 | 118 | 103 | 7 | CID000004114 | |
| Drug | alpha-naphthoflavone | 1.10e-06 | 118 | 103 | 7 | CID000011790 | |
| Drug | Azamulinum | 1.15e-06 | 18 | 103 | 4 | CID003086060 | |
| Drug | 11,12,15-trihydroxyeicosatrienoic acid | 1.28e-06 | 42 | 103 | 5 | CID006439610 | |
| Drug | clofibrate | CYP3A7 CYP2C18 TMEM176B CYP4B1 CYP4F2 RXRA GSTM2 CYP4F3 CYP4F12 CYP4F11 | 1.50e-06 | 311 | 103 | 10 | CID000002796 |
| Drug | naphthalene-1,2-dihydrodiol | 1.82e-06 | 45 | 103 | 5 | CID000000362 | |
| Drug | chloral hydrate | 2.01e-06 | 129 | 103 | 7 | CID000002707 | |
| Drug | nitro-L | 2.52e-06 | 48 | 103 | 5 | CID000006849 | |
| Drug | 19-HETE | 2.80e-06 | 49 | 103 | 5 | CID006439528 | |
| Drug | Bromocryptine mesylate [22260-51-1]; Down 200; 5.4uM; PC3; HG-U133A | 2.86e-06 | 194 | 103 | 8 | 1925_DN | |
| Drug | trichloroethylene | 2.97e-06 | 88 | 103 | 6 | CID000006575 | |
| Drug | 6-hydroxymelatonin | 3.10e-06 | 50 | 103 | 5 | CID000001864 | |
| Drug | dioxin | CYP3A7 CYP2C18 CYP4B1 ESR1 CYP4F2 UGT2A3 CYP4F3 CYP4F12 CYP4F11 EPAS1 | 3.99e-06 | 347 | 103 | 10 | CID000015625 |
| Drug | 9-hydroxybenzo(a)pyrene | 4.15e-06 | 53 | 103 | 5 | CID000028598 | |
| Drug | PCB 77 | 5.56e-06 | 98 | 103 | 6 | CID000036187 | |
| Drug | 1,2-dihydroxynaphthalene | 5.97e-06 | 57 | 103 | 5 | CID000011318 | |
| Drug | 17-ODYA | 7.70e-06 | 60 | 103 | 5 | CID000001449 | |
| Drug | 1,1-dichloroethylene | 7.70e-06 | 60 | 103 | 5 | CID000006366 | |
| Drug | trichloroacetic acid | 9.24e-06 | 107 | 103 | 6 | CID000006421 | |
| Drug | 3-methylcholanthrene | 1.03e-05 | 231 | 103 | 8 | CID000001674 | |
| Drug | rifampicin | CYP3A7 CYP2C18 CYP4B1 ESR1 CYP4F2 UGT2A3 CYP4F3 CYP4F12 CYP4F11 | 1.06e-05 | 306 | 103 | 9 | CID005381226 |
| Drug | NSC9700 | MYH3 CYP3A7 MYH11 CYP2C18 CYP4B1 ESR1 CYP4F2 UGT2A3 CYP4F3 CYP4F12 ATM CYP4F11 | 1.20e-05 | 578 | 103 | 12 | CID000005408 |
| Drug | 3 -hydroxypregn-5-en-20-one | 1.28e-05 | 238 | 103 | 8 | CID000001027 | |
| Drug | piperonyl butoxide | 1.33e-05 | 67 | 103 | 5 | CID000005794 | |
| Drug | 5,6-epoxyeicosatrienoic acid | 1.43e-05 | 68 | 103 | 5 | CID000001778 | |
| Drug | 8(9)-EET | 1.53e-05 | 69 | 103 | 5 | CID000001901 | |
| Drug | 4-bromophenol | 1.65e-05 | 70 | 103 | 5 | CID000007808 | |
| Drug | metyrapone | 1.73e-05 | 179 | 103 | 7 | CID000004174 | |
| Drug | nifedipine | MYH3 CYP3A7 MYH11 CYP2C18 CYP4B1 CYP4F2 MYLK2 CYP4F3 CYP4F12 CYP4F11 | 1.90e-05 | 415 | 103 | 10 | CID000004485 |
| Drug | chloral | 2.02e-05 | 73 | 103 | 5 | CID000006407 | |
| Drug | senecionine | 2.16e-05 | 74 | 103 | 5 | ctd:C009237 | |
| Drug | C20H32O4 | 2.79e-05 | 78 | 103 | 5 | CID000001440 | |
| Drug | alprazolam | 2.81e-05 | 193 | 103 | 7 | CID000002118 | |
| Drug | 7-BFC | 3.16e-05 | 14 | 103 | 3 | CID000848780 | |
| Drug | Paroxetine maleate [64006-44-6]; Down 200; 1uM; PC3; HT_HG-U133A | 3.21e-05 | 197 | 103 | 7 | 4556_DN | |
| Drug | tolbutamide | 3.31e-05 | 198 | 103 | 7 | CID000005505 | |
| Drug | Torsemide [56211-40-6]; Up 200; 11.4uM; HL60; HT_HG-U133A | 3.42e-05 | 199 | 103 | 7 | 2956_UP | |
| Drug | dichloran | 3.52e-05 | 41 | 103 | 4 | CID000007430 | |
| Drug | beta-naphthoflavone | 3.53e-05 | 200 | 103 | 7 | CID000002361 | |
| Drug | benzo(a)pyrene | CYP3A7 CYP2C18 CYP4B1 ESR1 OPRK1 UGT2A3 CYP4F12 CYP4F11 HSPA4 | 3.64e-05 | 358 | 103 | 9 | CID000002336 |
| Drug | AC1Q5W8U | 3.93e-05 | 15 | 103 | 3 | CID000006483 | |
| Drug | aniline | 4.61e-05 | 142 | 103 | 6 | CID000006115 | |
| Drug | polybrominated biphenyl | 4.67e-05 | 44 | 103 | 4 | CID000042948 | |
| Drug | Aroclor 1254 | 5.27e-05 | 213 | 103 | 7 | CID000040470 | |
| Drug | 14(15)-EpETrE | 5.28e-05 | 89 | 103 | 5 | CID000001431 | |
| Drug | NSC98537 | CYP3A7 CYP2C18 CYP4B1 ESR1 CYP4F2 PIK3C2B CYP4F3 CYP4F12 ATM CYP4F11 | 5.73e-05 | 473 | 103 | 10 | CID000005410 |
| Drug | licoflavone | 6.06e-05 | 3 | 103 | 2 | CID005319000 | |
| Drug | p-nitroanisole | 6.18e-05 | 92 | 103 | 5 | CID000007485 | |
| Drug | AC1L1BEQ | 6.51e-05 | 93 | 103 | 5 | CID000001407 | |
| Drug | pleuromutilin | 6.98e-05 | 18 | 103 | 3 | CID000031326 | |
| Drug | bromobenzene | 7.96e-05 | 97 | 103 | 5 | CID000007961 | |
| Drug | halothane | 9.15e-05 | 314 | 103 | 8 | CID000003562 | |
| Disease | hypertension (biomarker_via_orthology) | 1.19e-05 | 227 | 99 | 7 | DOID:10763 (biomarker_via_orthology) | |
| Disease | Uterine leiomyoma, breast carcinoma | 1.69e-04 | 32 | 99 | 3 | EFO_0000305, HP_0000131 | |
| Disease | syndromic X-linked intellectual disability Najm type (implicated_via_orthology) | 2.31e-04 | 7 | 99 | 2 | DOID:0060807 (implicated_via_orthology) | |
| Disease | infertility (implicated_via_orthology) | 2.31e-04 | 7 | 99 | 2 | DOID:5223 (implicated_via_orthology) | |
| Disease | Inherited neuropathies | 3.31e-04 | 40 | 99 | 3 | C0598589 | |
| Disease | hexadecenedioate (C16:1-DC) measurement | 3.95e-04 | 9 | 99 | 2 | EFO_0800562 | |
| Disease | myopathy (implicated_via_orthology) | 5.68e-04 | 48 | 99 | 3 | DOID:423 (implicated_via_orthology) | |
| Disease | fetal genotype effect measurement, body weights and measures | 6.03e-04 | 49 | 99 | 3 | EFO_0004324, EFO_0007959 | |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 7.60e-04 | 53 | 99 | 3 | C4707243 | |
| Disease | ecosanoids measurement | 8.47e-04 | 55 | 99 | 3 | EFO_0020044 | |
| Disease | melanoma | 8.72e-04 | 126 | 99 | 4 | EFO_0000756 | |
| Disease | forced expiratory volume | CYP3A7 ZNF337 ESR1 SLC44A4 PIK3C2B ATAD2B ADAMTS17 MEIOSIN HSPA4 | 1.36e-03 | 789 | 99 | 9 | EFO_0004314 |
| Disease | Uterine leiomyoma, estrogen-receptor positive breast cancer | 1.65e-03 | 18 | 99 | 2 | EFO_1000649, HP_0000131 | |
| Disease | metabolonic lactone sulfate measurement | 1.84e-03 | 19 | 99 | 2 | EFO_0800659 | |
| Disease | level of Sterol ester (27:1/20:3) in blood serum | 1.84e-03 | 19 | 99 | 2 | OBA_2045199 | |
| Disease | BREAST CANCER | 2.24e-03 | 21 | 99 | 2 | 114480 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RDFFMRMKCTVTNRG | 166 | Q99814 | |
| KRCNDMMTLGRLRGF | 331 | Q86VW2 | |
| EEFRQMMGCFRNQKF | 86 | O60911 | |
| QCRRFYNFLMADNMK | 251 | P08910 | |
| MMRRRFEECNVGQIK | 226 | Q9H211 | |
| CFMNKRFRLGFMATF | 371 | P32238 | |
| GKNRMDVFSQNMFCA | 626 | P00736 | |
| MQMRESCIKLQAFVR | 1726 | Q8IZT6 | |
| NKMVFRRCTIMGSEY | 441 | O94823 | |
| CQILFGMNATFCRNM | 476 | Q8TE56 | |
| MLKCRQFVEMVNGTD | 331 | Q6VN20 | |
| RCLVNFNILMEDKMN | 101 | Q9Y5G6 | |
| MMNLVLCFTGFRKKE | 176 | Q9H8V3 | |
| FRRAMLAMFKCQTHQ | 301 | O14718 | |
| PLCQRMGAMVAFRRF | 1361 | O00763 | |
| CGMDRRQNTYIMDKG | 906 | A6BM72 | |
| MNRGKFLEMCNDLLA | 301 | P34932 | |
| FGFRCPQEMFQRMED | 86 | Q4VC12 | |
| KESMGMCFIGKRNFE | 216 | O75648 | |
| LFVFCFRMKMRSETA | 61 | Q99677 | |
| KSMARARNRCLPMNF | 351 | Q9ULI0 | |
| RMMNLQGEEFVCLKS | 436 | P03372 | |
| NKEMMVAMRRRCSQF | 291 | Q8NGB9 | |
| RGKTRRMMNDSCQNL | 106 | Q8IYT4 | |
| FVRQICDGILFMHKM | 386 | Q9H1R3 | |
| KGVFSGLRNMNCIEM | 176 | P21810 | |
| ENQFMDSRMQLAKLC | 101 | P28161 | |
| VFLAQKMMIGRCNRA | 306 | P14618 | |
| FMMSQQQGRRFKRAT | 1091 | Q6ZVL6 | |
| FNFCSRRFTMKTVLM | 101 | Q8N752 | |
| QRLGMCAKEMVIFFG | 336 | Q8WVZ9 | |
| GKLQAYRLICAMMTR | 1011 | Q2PPJ7 | |
| CQMRMTGAIRKQLAA | 4211 | Q7Z6Z7 | |
| KKCVNGFIMFCRMNR | 541 | C9JSJ3 | |
| GFIMFCRMNRKQYIR | 546 | C9JSJ3 | |
| VQEGLDMRMVIFRCF | 1106 | O00750 | |
| MVCQKFCRDMTFDLR | 66 | B3GLJ2 | |
| MGNGMCSRKQKRIFQ | 1 | O00461 | |
| LTLGMRRKNTCQNFM | 41 | Q9UJ42 | |
| RRFNIKMCFDMLNSL | 731 | Q9HAP2 | |
| KMGIEQNMCEVNRSF | 556 | Q13315 | |
| MVVFGECLRKAAMFT | 166 | O60725 | |
| ANIMRMSDGLFLQKC | 201 | P50213 | |
| FCVFRNLMKMSVFPR | 981 | Q8IZD9 | |
| RNCIGQAFAMAEMKV | 466 | Q9HBI6 | |
| RRFSTMPFMFCNINN | 1511 | P29400 | |
| RNCIGQAFAMAEMKV | 466 | Q9HCS2 | |
| RNCIGQTFAMAEMKV | 466 | P78329 | |
| RLLMLSGNNICFSFM | 326 | Q5MNV8 | |
| CVSAKNAFMLLMRNI | 571 | Q53GD3 | |
| FCLMTLRNFGMGKRS | 126 | P33260 | |
| RNCIGQQFAMSEMKV | 451 | P13584 | |
| RNCIGQAFAMAEMKV | 466 | Q08477 | |
| FMSCNLITGMFQRLD | 336 | P26641 | |
| ERENIRKMQGLMFRC | 21 | Q96C01 | |
| NCIGMRFALVNMKLA | 441 | P24462 | |
| PFFRNMNFKRLEAGM | 446 | P34947 | |
| RNSRMNKEPCFFRAM | 356 | Q8NFL0 | |
| ARCSSIFMMQRFGRK | 376 | Q9Y226 | |
| RYQKCLAMGMKREAV | 191 | P19793 | |
| QRLGMCAKEMVIFFG | 336 | Q86V97 | |
| KSCMRELENMGQQAR | 796 | Q9HC10 | |
| MLLCFRFGNQSMKRE | 1 | P30954 | |
| FRDFCFPLKMRMERQ | 341 | P41145 | |
| QLLFEMCKGVRNMFH | 226 | O75691 | |
| GIMRFINMQTCKLLF | 286 | Q96DN5 | |
| FNFCSRRFTMKTVLM | 101 | P48729 | |
| CNMKFMTQSAFERAL | 741 | Q9C0D5 | |
| NLSRCRRKMNDFGMA | 1296 | Q9HCD6 | |
| AVCRGFLMRVEFQKM | 791 | P11055 | |
| DDARYMKGCLNMRTQ | 471 | O15457 | |
| MVMYARKQQRLSDGC | 1 | Q9BTA9 | |
| NAEMARMLLKRGCNV | 296 | O60733 | |
| QLFERMCMALGGRAS | 621 | Q9UQ90 | |
| GMMLLIFARKDQCRY | 321 | Q01968 | |
| ECRAYMQMLRKLFTA | 191 | Q3YBM2 | |
| MKFGTIFCGRMRNLE | 36 | Q16533 | |
| IFCGRMRNLEKNMFT | 41 | Q16533 | |
| MFVRFMGNFEKTCLI | 546 | Q86X52 | |
| ALFQGCDRQMIFDML | 961 | Q14028 | |
| MAFQAMCRGYLARKA | 791 | P35749 | |
| ICMFNNMGKIEFRDS | 296 | Q9BXT8 | |
| NTFCCDGRVMMARQK | 21 | Q9Y397 | |
| RRQAMPFKCMQLTDF | 46 | P50914 | |
| DFLCNFLIKMGMTRT | 111 | Q8N0X2 | |
| FLIKMGMTRTLDCFQ | 116 | Q8N0X2 | |
| CFVGQAGQKLMMSQR | 666 | Q9Y263 | |
| NFARMRKMADFFLIQ | 181 | Q8WW62 | |
| CGREFTLQANMKRHM | 496 | Q8N1W2 | |
| GHGMMFVRNDCKVFR | 16 | Q9UHA3 | |
| GFRSFLKILTCMQGM | 501 | Q8IWV7 | |
| ALAFSCFTELMKRMN | 996 | Q2NKQ1 | |
| RNKFFCNGRIMMARQ | 46 | Q8IZN3 | |
| NCRRFMDRCMPEAFK | 171 | Q9UPU5 | |
| NDFFVEIRGTLKMMC | 111 | Q6UWM9 | |
| LIKSMFTTFGMEQCR | 206 | Q15695 | |
| ANTRMGLLQEKMGFC | 401 | Q8NEE8 | |
| FKVDGDQASFMMNCR | 146 | Q6P9A1 | |
| IINMKIKLFMNCRGR | 991 | Q9NYU1 | |
| MKDQVRAAMTCIRFF | 2261 | Q68DK2 | |
| LIKSMFTTFGMEQCR | 201 | Q15696 | |
| GGYRDKMRMQRIKVC | 21 | Q8IUB3 | |
| MGEICRKDFLARNMT | 101 | Q6ZT98 | |
| KCAERGQDFSRKMMV | 181 | Q9Y3M9 | |
| AVFQMLKSMCAGQRL | 71 | Q6P582 | |
| AVFQMLKSMCAGQRL | 71 | Q6NZ67 |